COPD Drugs Linked To Increased Cardiovascular Health Risks: Study
Some COPD treatments can significantly increase the risk of severe heart problems after just one month of treatment, according to the findings of a new study.
Tag Archives: Advair
-
-
FDA Removes Advair, Symbicort Boxed Warnings For Death Risks
The FDA is removing a black box warning from certain asthma inhalers, saying that evidence shows they do not carry the increased risk of severe asthma side effects and death…
-
Advair Settlement Agreement Reached With 45 States for $105M
GlaxoSmithKline will pay 45 states $105 million for illegally marketing the asthma drug Advair.
-
Spiriva, Serevent COPD Drugs Could Increase Heart Problem Risk: Study
The findings of a new study resurrects concerns that some long-acting inhalers used to treat chronic pulmonary obstructive disease (COPD), such as Spiriva and Serevent, could increase the risk of…
-
Advair Lawsuit Filed Over Severe Asthma Attack That Caused Brain Injury
A Texas mother is suing GlaxoSmithKline over the side effects of Advair, an asthma medication she says nearly killed her son and left him brain damaged.
-
Asthma Drug Birth Defect Risk Seen When Used in Pregnancy: Study
A new study suggests a link between specific birth defects and asthma medication use during pregnancy, raising concerns about the safety of popular drugs like Advair and Symbicort among expectant…
-
Studies Ordered for Side Effects of Symbicort, Advair Diskus, Dulera, Foradil
Federal drug regulators have ordered that new studies be done to examine potential safety problems with a number of asthma drugs, including Advair, Symbicort, Dulera and Foradil.
-
Risk of Problems from Asthma Drugs Lead to New FDA Warnings
Federal regulators have moved to restrict the use of Advair, Symbicort, Foradil and Serevent, after determining that side effects of the asthma drugs may increase the risk of severe asthma…
-
Advair Ineffective in Some Children with Gene Variant: Study
British researchers have found that perhaps as many as 10% of children may not respond to Advair and other albuterol-based asthma treatments due to a gene variant, potentially increasing the…
-
FDA Panel Indicates Foradil and Serevent Should Not Be Used for Asthma
An FDA advisory panel, which met Wednesday and Thursday to review long-acting asthma inhaler risks, has indicated that Foradil and Serevent should no longer be approved for treatment of asthma.…
